Kerry Wentworth

Insider Reports History

Location
New York, NY
Signature
/s/ Stephen Dang, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kerry Wentworth:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nuvation Bio Inc. CHIEF REGULATORY OFFICER Class A Common Stock 50,000 $90,000 $1.80 16 Jun 2025 Direct
Nuvation Bio Inc. CHIEF REGULATORY OFFICER Stock Option (Right to Buy) 500,000 28 Feb 2025 Direct
Flexion Therapeutics Inc Chief Regulatory Officer Common Stock 0 $8.50 19 Nov 2021 By Spouse
Flexion Therapeutics Inc Chief Regulatory Officer Common Stock 0 $8.50 19 Nov 2021 Direct
Flexion Therapeutics Inc Chief Regulatory Officer Stock Option (right to buy) 0 19 Nov 2021 Direct

Insider Reports Filed by Kerry Wentworth

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NUVB Nuvation Bio Inc. 16 Jun 2025 2 +$89,740 4 CHIEF REGULATORY OFFICER 18 Jun 2025, 16:05
NUVB Nuvation Bio Inc. 28 Feb 2025 1 $0 4 CHIEF REGULATORY OFFICER 04 Mar 2025, 18:37
NUVB Nuvation Bio Inc. 29 Feb 2024 1 $0 4 CHIEF REGULATORY OFFICER 04 Mar 2024, 17:25
NUVB Nuvation Bio Inc. 28 Feb 2023 1 $0 4 Chief Regulatory Officer 02 Mar 2023, 16:57
NUVB Nuvation Bio Inc. 29 Aug 2022 1 $0 4 Chief Regulatory Officer 31 Aug 2022, 17:18
NUVB Nuvation Bio Inc. 23 May 2022 2 $0 4 Chief Regulatory Officer 25 May 2022, 16:36
/report/000120919121065709-wentworth-kerry-2021-11-19 Flexion Therapeutics Inc 19 Nov 2021 11 -$1,248,166 4 Chief Regulatory Officer 19 Nov 2021, 09:04
/report/000120919121047504-wentworth-kerry-2021-07-19 Flexion Therapeutics Inc 19 Jul 2021 1 -$25,439 4 Chief Regulatory Officer 20 Jul 2021, 20:49
/report/000120919121043523-wentworth-kerry-2021-06-21 Flexion Therapeutics Inc 21 Jun 2021 1 +$4,193 4 Chief Regulatory Officer 28 Jun 2021, 18:09
NUVB Nuvation Bio Inc. 23 May 2020 0 $0 3 Chief Regulatory Officer 25 May 2022, 16:35